Introduction: Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain.
Introduction:
Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves DEN for patients with inadequate clinical response, immediate DEN may accelerate recovery by achieving earlier clearance of necrotic material.
Why was this study needed?:
The ideal timing of DEN after EUS-guided drainage has not been established.
The drainage-oriented step-up approach delays necrosectomy until clinically indicated.
Earlier necrotic tissue removal may shorten recovery without increasing complications.
Randomized evidence comparing immediate versus on-demand DEN has been lacking.
Results:
In the multicenter WONDER-01 randomized trial, immediate DEN significantly shortened the time to clinical success compared with the conventional drainage-oriented step-up strategy. Technical success was similarly high in both groups, and rates of procedure-related adverse events and mortality were comparable. However, all patients assigned to immediate DEN underwent necrosectomy, whereas fewer than half of those managed with the step-up approach ultimately required the procedure, highlighting that many patients can recover with drainage alone.
Clinical Impact:
Immediate DEN offers faster clinical resolution without compromising safety, making it an attractive option for patients in whom rapid recovery is desirable. However, because the step-up approach avoids unnecessary necrosectomy in a substantial proportion of patients, it remains an efficient and less invasive strategy. Treatment decisions should therefore be individualized based on disease severity, clinical response, and local expertise.
Bottom Line:
Immediate endoscopic necrosectomy after EUS-guided drainage accelerates recovery without increasing adverse events but results in more necrosectomy procedures, supporting individualized selection between immediate and step-up treatment strategies.
Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal bypass liner (DJBL) is an endoscopically placed...
Introduction: Bevacizumab is widely used in metastatic colorectal cancer (mCRC) because of its survival benefits but is associated with impaired wound healing, gastrointestinal perforation, and bleeding. These concerns often lead clinicians to delay endoscopic procedures...
Introduction: Endoscopic submucosal dissection (ESD) enables en bloc resection of large colorectal neoplasms with excellent oncological outcomes. However, concerns about perforation have limited its widespread adoption. This large prospective multicenter study evaluated the incidence, risk...
Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity, diabetes, and MASLD. However, many patients discontinue...
Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This multicenter prospective study evaluated whether directly placing...
Introduction: Although Roux-en-Y gastric bypass (RYGB) is an effective bariatric procedure, a small proportion of patients develop severe nutritional complications, refractory dumping syndrome, or other debilitating adverse events requiring reversal. This study describes a novel...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.